Functional study of the renal effect of the anticholimesterase paraoxon.
D000109:Acetylcholine / Q000494:pharmacology; D000818:Animals; D001285:Atropine / Q000494:pharmacology; D002712:Chlorides / Q000378:metabolism; D002800:Cholinesterase Inhibitors / Q000494:pharmacology*; D004285:Dogs; D005260:Female; D006145:Guanethidine / Q000494:pharmacology; D007269:Injections, Intra-Arterial; D007275:Injections, Intravenous; D007668:Kidney / Q000187:drug effects*; D007684:Kidney Tubules / Q000187:drug effects; D008297:Male; D008657:Metabolic Clearance Rate / Q000187:drug effects; D008722:Methods; D009596:Nitrophenols / Q000494:pharmacology*; D010643:Phenoxybenzamine / Q000494:pharmacology; D010710:Phosphates / Q000378:metabolism; D010756:Phosphoric Acids / Q000494:pharmacology*; D010830:Physostigmine / Q000494:pharmacology; D011188:Potassium / Q000378:metabolism; D012964:Sodium / Q000378:metabolism; D013997:Time Factors
D002712:Chlorides; D002800:Cholinesterase Inhibitors; D009596:Nitrophenols; D010710:Phosphates; D010756:Phosphoric Acids; D010643:Phenoxybenzamine; D001285:Atropine; D012964:Sodium; D010830:Physostigmine; D000109:Acetylcholine; D011188:Potassium; D006145:Guanethidine